$EyePoint Pharmaceuticals (EYPT.US)$ 10% Shareholder Cormorant Asset Management, LP purchased 850K shares of common stock on May 6, 2024 at an average price of $11.86 for a total value of $10.08 million.
This transaction involves other related parties: Chen Bihua and Cormorant Global Healthcare Master Fund, LP.
What is statement of changes in beneficial ownership of securities?
It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.